Futu Information on December 2 | Hong Kong stocks rose in early trading and rebounded in the afternoon. The Hang Seng Technology Index performed relatively strongly, closing up 1.03%, while the Hang Seng Index and the National Index fell 0.33% and 0.25% respectively. There was a net outflow of HK $1.253 billion from southward funds throughout the day.

As of the close, Hong Kong stocks rose 837, fell 978, and closed flat at 1132.

The specific industry performance is shown below:

In terms of the plate, some science and Internet stocks rose slightly.Kuaishou Technology rose nearly 4%, Meituan rose more than 3%, BABA rose more than 2%, Bilibili Inc. rose more than 1%, and Tencent rose slightly.

Most gaming stocks are up.Wynn Macau rose more than 4%, while Melco International Development, MGM China and SJM Holdings rose nearly 4%.

Catering stocks strengthenHelen rose by more than 8%, Haidilao International Holding and Jiabu by more than 7%, and 99 cents by more than 3%.

Coal stocks are weakeningYanzhou Mining Energy fell more than 5%, China Coal Energy fell more than 4%, China Shenhua Energy fell more than 3%.

Internet medical concept stocks are strong throughout the day.Ping An Healthcare And Technology rose by more than 15%, Alibaba Health Information Technology and JD Health by more than 9%.

Inner housing stocks and property management stocks fell collectively.Longguang Group fell by more than 6%, Xuhui Yongsheng Service fell by more than 5%, Country Garden Holdings, Longfor Group and Country Garden Services Holdings fell by more than 4%.

Individual stocks$KUAISHOU-W (01024.HK)$Up nearly 4%, Goldman Sachs Group maintained his rating, referring to further reducing costs and optimizing profit margins.

$ALI HEALTH (00241.HK)$On news, the measures for the Supervision and Administration of Drug Network sales have been formally implemented since December 1, which provides for the management of drug network sales, the implementation of platform responsibilities, supervision and inspection measures, and legal liability.

$Haidilao International Holding (06862.HK)$Up more than 7%, CICC said that the consumer sector where growth was suppressed in the previous period is expected to rebound and repair.

$GOME RETAIL (00493.HK)$Fell more than 14% after Gome denied it had been filed for bankruptcy liquidation.

Today's turnover of Hong Kong shares TOP20

Institutional viewpoint

• Goldman Sachs Group: first give COSCO Shipping Holdings a sell rating and reiterate the purchase of China Merchants Port and Cosco Marine Port.

Goldman Sachs Group published a report and gave it for the first time.$COSCO SHIP HOLD (01919.HK)$The sell rating indicated that it was not optimistic about the container shipping industry, and expected that the profits of shipping companies would also fall due to oversupply and lower freight rates. The bank forecasts that COSCO Shipping Holdings's adjusted freight costs will peak this year and will fall by 46 per cent, 26 per cent and 21 per cent respectively over the next three years, while unit costs will grow at an annual rate of 2 per cent. It forecasts that the company's EBIT profit margin will gradually fall back from 43 per cent this year to 15 per cent, 4 per cent and a loss of 11 per cent between 2023 and 2025, with a target price of HK $6.80. In contrast, Goldman Sachs Group is more optimistic about the defensive ability of the port industry, believing that although the shipping market is in a period of decline, tariffs continue to rise. Goldman Sachs Group reiterated his commitment to$CHINA MER PORT (00144.HK)$及$COSCO SHIP PORT (01199.HK)$The latest target prices are HK $13.5 and HK $6.9 respectively.

• CITIC: first give Wuxi Biologics a buy rating, with a target price of HK $67

CITIC issued a report that$WUXI BIO (02269.HK)$There are plenty of orders on hand, and the medium-term performance growth has strong certainty. At present, the company has completed the construction of platform, industrialization and internationalization, and has obvious leading advantages. With the continuous promotion of the company's strategy and global production capacity building, the future pipeline projects are gradually promoted, which is expected to bring continuous impetus to the company's long-term performance. The report pointed out that with the bottoming out of global health investment and financing, and the easing of international geopolitical concerns about the impact of industrial chain cooperation, the factors of early valuation pressure have also gradually decreased. The bank expects the company to achieve net profit of 4.577 billion yuan, 6.004 billion yuan and 7.791 billion yuan respectively from this year to the year after next, corresponding to earnings per share forecast of 1.08,1.42 and 1.85 yuan respectively, with a target price of 67 Hong Kong dollars. Cover for the first time to give a buy rating.

• UBS: downgrade Zhongsheng Group target price to HK $29, rating sell

UBS issued a report believing that$ZHONGSHENG HLDG (00881.HK)$Gross margins on new cars peaked last year, as did valuations, and disagreed with market expectations that the group's sales of high-end cars would grow by double digits next year. The bank mentioned that common prosperity and new energy vehicles pose a threat to traditional high-end OEM (contract manufacturing) and will have a long-term impact on car dealers, and it is estimated that in the current macro environment, the valuation of the dealer industry will continue to be reassessed. UBS cut its profit forecast for this year to 2024 by 5% to 6%, and its gross profit margin for new cars this year and next is expected to be 2.3% and 2.4% respectively, down from 4.4% last year. The target price was lowered from HK $33 to HK $29 and the rating maintained the sell.

For more popular sections, please see "Futu Niuniu app- Market-Thermal Map":